Establishment Labs Holdings Inc. · NASDAQ:ESTA
Establishment Labs — 2020 Wells Fargo Virtual Healthcare Conference
14 slides from Establishment Labs's conference presentation, Sep 9, 2020
Slide 1: Establishment Labs Holdings Inc. (NASDAQ: ESTA)
Establishment Labs Holdings Inc. (NASDAQ: ESTA) Juan José Chacón-Quirós Founder and Chief Executive Officer Renee Gaeta Chief Financial Officer September 9, 2020
Slide 2: Safe Harbor and Forward Looking Statements
PROPRIETARY INFORMATION OF ESTABLISHMENT LABS HOLDINGS INC. (“Establishment Labs”) Safe Harbor The information contained in this document is Establishment Labs’ PROPRIETARY INFORMATION and is disclosed in CONFIDENCE. It is the property of Establishment Labs and and shall not be used, disclosed to ot
Slide 3: Company Overview
C) Establishment Labs Company Overview
Slide 4: A Global Presence in More Than 80 Countries
A Global Presence in More Than 80 Countries • $90M sales in 2019, a 46% y-o-y increase • ~500 employees • Headquartered in Costa Rica • 2 state-of-the-art manufacturing facilities • Broad patent portfolio • Experienced management team Market Presence Direct Markets Future Pending Markets 4
Slide 5: Strong Financial Performance
Strong Financial Performance Revenue Gross Profit Margin $ in millions $89.6 61% $61.2 59% 51% $34.7 2017 2018 2019 2017 2018 2019 Q1 Q2 Q3 Q4 Column1 5
Slide 6: 1H 2020 Highlights
1H 2020 Highlights • Q1: Record sales of $24.5M at the higher end of guidance • Q2: Sales challenging, but improvement seen throughout the quarter Q3 sales guidance of $18-$21M* ($22.9M in Q3 2019) • Q2: Successfully lowered operating expenses by 27% over Q1 On track to reduce planned 2020 expen
Slide 7: A Leader in Breast Aesthetics
A Leader in Breast Aesthetics
Slide 8: Breast Aesthetics Market Dynamics
Breast Aesthetics Market Dynamics • Relatively little innovation in implant technology since the 1990s • Large competitors focused on other segments • Many very small competitors, often regionally focused • An ever-changing regulatory landscape • Global demand for breast augmentation procedures cont
Slide 9: What Makes Motiva Implants Different?
What Makes Motiva Implants Different? ® 1 • A new silicone shell • A new silicone gel family • New safety features • A new implant surface 9
Slide 10: Motiva's Unique Surface Demonstrates Positive Clinical Outcomes
Motiva’s Unique Surface Demonstrates Positive Clinical Outcomes 10
Slide 11: Robust Safety and Performance Data
Robust Safety and Performance Data Innovative technology, and a strong foundation of science and research, helped ESTA achieve the one million Motiva Implants milestone in 2019 ® 11
Slide 12: Driving Continued Growth
Driving Continued Growth • Organic growth in our existing markets • Entering new markets • Expanding our direct sales model • Developing new and innovative products Products not for sale in the U.S. 12
Slide 13: Establishment Labs is Well-Positioned for Continued Growth and Success
Establishment Labs is Well-Positioned for Continued Growth and Success • The most comprehensive product portfolio in breast aesthetics market • Demonstrated safety profile • Gaining market share • Sizable new markets • Innovative product pipeline • Disciplined financial management • Entrepreneurial
Slide 14: Establishment Labs Holdings Inc. (NASDAQ: ESTA)
Establishment Labs Holdings Inc. (NASDAQ: ESTA) Our Vision: To transform our industry by focusing on women’s health and creating value for all stakeholders
Establishment Labs Holdings — 2020 Wells Fargo Virtual Healthcare Conference on 6ix